CRISPR Therapeutics Announces the Retirement of Tyler Dylan-Hyde and Appointment of Shelby Walker as Head of … – EIN News (press release)
registrarjournal.com |
CRISPR Therapeutics Announces the Retirement of Tyler Dylan-Hyde and Appointment of Shelby Walker as Head of …
EIN News (press release) “Tyler joined CRISPR in its early stages and made significant contributions to the Company's success during his tenure,” commented Samarth Kulkarni, PhD, Chief Executive Officer of CRISPR Therapeutics. “On behalf of CRISPR, I give Tyler our deepest … Crispr Therapeutics (NASDAQ:CRSP) Raised to “C” at TheStreet Crispr Therapeutics (CRSP) Upgraded by TheStreet to C |
